Structure Therapeutics' (GPCR) subsidiary Gasherbrum Bio signed a patent license agreement with Genentech, granting Genentech ...
Structure Therapeutics, through its subsidiary Gasherbrum, entered into a non-exclusive patent license with Genentech, the US ...
Lilly has seen dramatic sales growth over the last couple of years from its injectable, dual GLP-1/GIP agonist obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback